Tower View Wealth Management’s Alpha Tau Medical DRTS Stock Holding History

Tower View Wealth Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.4K	Hold	5,566	–	–	0.02%	102
2025 Q4	$27.6K	Hold	5,566	–	–	0.01%	102
2025 Q3	$25.1K	Hold	5,566	–	–	0.01%	103
2025 Q2	$17.4K	Hold	5,566	–	–	0.01%	123
2025 Q1	$14K	Hold	5,566	–	–	0.01%	120
2024 Q4	$17.3K	Hold	5,566	–	–	0.01%	109
2024 Q3	$13.2K	Hold	5,566	–	–	0.01%	124
2024 Q2	$14.1K	Hold	5,566	–	–	0.01%	118
2024 Q1	$16.4K	Hold	5,566	–	–	0.01%	118
2023 Q4	$17K	Hold	5,566	–	–	0.01%	112
2023 Q3	$21K	Hold	5,566	–	–	0.01%	98
2023 Q2	$24K	Hold	5,566	–	–	0.02%	95
2023 Q1	$16K	Hold	5,566	–	–	0.01%	103
2022 Q4	$18K	Hold	5,566	–	–	0.01%	102
2022 Q3	$33K	Buy	+5,566	New	+$49.1K	0.03%	89

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Tower View Wealth Management's DRTS Position: Q1 2026 in Review

Tower View Wealth Management held its Alpha Tau Medical (DRTS) position steady in Q1 2026 at 5,566 shares worth $39.4K. The position accounts for 0.02% of the portfolio, ranked #102.

Tower View Wealth Management first reported a position in DRTS in Q3 2022 and has held it in 15 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Tower View Wealth Management held 5,566 shares of Alpha Tau Medical worth $39.4K as of Q1 2026.
Tower View Wealth Management left its Alpha Tau Medical share count unchanged in Q1 2026.
Alpha Tau Medical made up 0.02% of Tower View Wealth Management's portfolio in Q1 2026, its #102 holding.
Tower View Wealth Management first reported a position in Alpha Tau Medical in Q3 2022 and has held it in 15 quarters since.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Tower View Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.